FIELD: medicine.
SUBSTANCE: what is declared is a method for inducing cell death ensured by inducing heat shock response in a cell in a combination with inhibition of an adaptive heat shock response. The invention may be used in medicine for preventing cancer, treating intracellular parasitic infections and inflammation-related conditions.
EFFECT: higher clinical effectiveness.
8 cl, 17 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF STRENGTHENING CYTOTOXIC EFFECTS OF PANOBINOSTAT ON TUMOR CELLS | 2023 |
|
RU2806371C2 |
| USE OF THIOCHROMENO[2,3-C]QUINOLINE-12-ONE COMPOUND FOR TREATING NON-SMALL CELLS LUNG CANCER | 2016 |
|
RU2663929C2 |
| COMBINED THERAPY WITH TYPE II ANTI-CD20 ANTIBODIES IN COMBINATION WITH PROTEASOME INHIBITOR | 2008 |
|
RU2520757C2 |
| COMBINATIONS OF SPECIFIC CLASS I HISTONE DEACETYLASE INHIBITORS AND PROTEASOME INHIBITORS | 2007 |
|
RU2456990C2 |
| PHARMACEUTICAL COMBINATIONS FOR TREATING A MALIGNANT TUMOR | 2017 |
|
RU2726367C2 |
| COMPOSITIONS AND METHODS FOR TREATING DISEASE | 2007 |
|
RU2482877C2 |
| EXOSOMES CONTAINING THE THERAPEUTIC POLYPEPTIDES | 2017 |
|
RU2737732C2 |
| CANCER IMMUNOTHERAPY | 2014 |
|
RU2744194C2 |
| APPLICATION OF HEAT SHOCK PROTEINS FOR IMPROVEMENT OF THERAPEUTICAL EFFECT OF NON-VACCINAL MEDICINAL EFFECT | 2003 |
|
RU2376029C2 |
| SYNERGIC COMBINATION OF PROTEASOME INHIBITOR AND VITAMIN K FOR INHIBITION OF GROWTH AND PROLIFERATION OF TUMOUR CELLS, PHARMACEUTICAL COMPOSITION AND THEREOF-BASED ANTI-TUMOUR MEDICATION | 2013 |
|
RU2563986C2 |
